Loading institutional data...
Loading institutional data...
Institutional ownership roughly stable: -0.14% change quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 10 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $66.94 today, the market must believe free cash flow compounds 12.9%/yr for a decade (off $1.4B normalized FCF).
The market's 12.9% is more optimistic than its 8-yr track record.
2-stage DCF · 0.54B shares · net debt $5.3B
mean 4.1% · volatility σ 34% · implied rate exceeded in 4/8 yrs
Central path = implied 12.9%/yr growth; shaded band = ±1σ (34%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Insufficient balance-sheet detail (needs retained earnings, working capital, equity).
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend exceeds free cash flow (113%) — funded from the balance sheet or debt, a red flag if it persists. Last year: $984M dividends + $0 buybacks = $984M returned on $871M FCF.
3 consecutive years of dividend increases · 3%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Modest payoff on reinvested capital. Current ROIC on all capital: 2%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $240M is below the $387M due within a year — relies on refinancing or operating cash flow. Scheduled principal only (excludes interest & revolver draws). As of 2026-03-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable. Effective rate ~4.0% on $5.5B of debt.
Cash of $240M fully covers short-term debt of $0.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-08-05 · 15d old
How a revenue dollar becomes profit — FY2026
Each value shows its share of revenue below it (common-size).
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.71B 100.0% | $4.40B 100.0% | $7.63B 100.0% | $8.44B 100.0% | $6.82B 100.0% | $5.44B 100.0% | $5.27B 100.0% | $5.35B 100.0% | $3.98B 100.0% | $3.41B 100.0% |
| Cost of Revenue | $1.99B 42.3% | $1.93B 43.9% | $2.64B 34.6% | $2.74B 32.5% | $2.37B 34.8% | $2.06B 37.9% | $2.03B 38.5% | $2.42B 45.2% | $1.56B 39.2% | $1.65B 48.4% |
| Cost of Products | — | — | — | — | — | — | — | — | $1.56B 39.2% | $1.65B 48.4% |
| Gross Profit | $2.72B 57.7% | $2.47B 56.1% | $5.00B 65.4% | $5.70B 67.5% | $4.45B 65.2% | $3.38B 62.1% | $3.24B 61.5% | $2.93B 54.8% | $2.42B 60.8% | $1.76B 51.6% |
| Research & Development | $1.09B 23.0% | $983.8M 22.4% | $1.10B 14.4% | $1.12B 13.3% | $989.1M 14.5% | $836.4M 15.4% | $877.8M 16.6% | $826.3M 15.4% | $529.3M 13.3% | $545.3M 16.0% |
| Selling, General & Admin | $674.3M 14.3% | $617.7M 14.0% | $734.2M 9.6% | $797.7M 9.5% | $718.9M 10.5% | $610.3M 11.2% | $676.6M 12.8% | $682.9M 12.8% | $452.1M 11.4% | $499.8M 14.7% |
| Total Operating Expenses | $2.23B 47.3% | $2.17B 49.3% | $2.42B 31.8% | $2.58B 30.6% | $2.60B 38.1% | $2.38B 43.8% | $2.60B 49.2% | $2.22B 41.4% | $1.48B 37.3% | $1.48B 43.5% |
| Operating Income | $490.1M 10.4% | $296.3M 6.7% | $2.57B 33.7% | $3.12B 36.9% | $1.85B 27.1% | $998.1M 18.4% | $647.1M 12.3% | $714.3M 13.4% | $936.3M 23.5% | $275.8M 8.1% |
| Interest Expense | $221.3M 4.7% | $259.2M 5.9% | $198.3M 2.6% | $203.9M 2.4% | $257.0M 3.8% | $356.9M 6.6% | $497.3M 9.4% | $502.9M 9.4% | $199.0M 5.0% | $146.3M 4.3% |
| Interest & Investment Income | $11.4M 0.2% | $9.2M 0.2% | $7.6M 0.1% | $2.1M 0.0% | $500K 0.0% | $1.7M 0.0% | $2.8M 0.1% | $8.1M 0.2% | $22.0M 0.6% | $3.1M 0.1% |
| Other Income (Expense), net | -$6.7M -0.1% | -$5.7M -0.1% | -$2.2M -0.0% | $3.8M 0.0% | $2.8M 0.0% | -$3.8M -0.1% | $3.2M 0.1% | -$2.2M -0.0% | -$5.8M -0.1% | $1.3M 0.0% |
| Pretax Income | $273.5M 5.8% | $38.9M 0.9% | $2.37B 31.0% | $2.91B 34.5% | $1.48B 21.7% | $339.5M 6.2% | $150.4M 2.9% | $204.5M 3.8% | $737.3M 18.5% | $89.8M 2.6% |
| Income Tax Expense | $43.5M 0.9% | $39.4M 0.9% | $459.0M 6.0% | $672.0M 8.0% | $197.0M 2.9% | -$9.9M -0.2% | -$420.2M -8.0% | -$151.4M -2.8% | $481.9M 12.1% | -$80.8M -2.4% |
| Net Income | $230.0M 4.9% | -$500K -0.0% | $1.91B 25.0% | $2.24B 26.5% | $1.29B 18.8% | $349.4M 6.4% | $570.6M 10.8% | $355.9M 6.7% | $255.4M 6.4% | $164.6M 4.8% |
| Per Share | ||||||||||
| EPS (Basic) | $0.22 | $-0.01 | $3.52 | $4.07 | $2.33 | $0.67 | $1.19 | $1.51 | $1.10 | $0.76 |
| EPS (Diluted) | $0.22 | $-0.01 | $3.48 | $4.02 | $2.27 | $0.65 | $1.11 | $1.42 | $1.03 | $0.71 |
| Weighted Avg Shares (Basic) | 540.4M | 537.3M | 542.0M | 550.4M | 552.3M | 519.2M | 477.7M | 236.2M | 232.9M | 217.2M |
| Weighted Avg Shares (Diluted) | 545.2M | 537.3M | 548.0M | 557.3M | 565.9M | 541.2M | 512.4M | 249.9M | 248.9M | 234.8M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
EOD close · as of 2026-08-05
Is the profit real, and how strong is the balance sheet?
FY2026 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 9.2× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 45.2 | 38.5 | 37.9 | 34.8 | 32.5 | 34.6 | 43.9 | 42.3 |
| Gross Profit | 54.8 | 61.5 | 62.1 | 65.2 | 67.5 | 65.4 | 56.1 | 57.7 |
| R&D | 15.4 | 16.6 | 15.4 | 14.5 | 13.3 | 14.4 | 22.4 | 23.0 |
| SG&A | 12.8 | 12.8 | 11.2 | 10.5 | 9.5 | 9.6 | 14.0 | 14.3 |
| Operating Income | 13.4 | 12.3 | 18.4 | 27.1 | 36.9 | 33.7 | 6.7 | 10.4 |
| Income Tax | -2.8 | -8.0 | -0.2 | 2.9 | 8.0 | 6.0 | 0.9 | 0.9 |
| Net Income | 6.7 | 10.8 | 6.4 | 18.8 | 26.5 | 25.0 | -0.0 | 4.9 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on MCHPP: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.